Chennai's Integral Coach Factory to Innovate Electronics for Hyperloop Technology
March 16, 2025 - 04:26
In a significant development for transportation technology, the Integral Coach Factory (ICF) in Chennai is set to advance electronics component technology specifically for Hyperloop systems. This initiative was highlighted during a recent visit by Vaishnaw to the Hyperloop facility at IIT Madras, which boasts the longest Hyperloop test track in Asia.
During his visit, Vaishnaw commended the efforts of IIT Madras and the Avishkar team, acknowledging their remarkable achievement in creating comprehensive test systems utilizing indigenous technologies. The focus on local innovation underscores India's commitment to developing cutting-edge transportation solutions that could potentially revolutionize travel.
The collaboration between ICF and IIT Madras aims to enhance the capabilities of Hyperloop technology, making it a viable option for the future of transportation. This partnership not only emphasizes the importance of homegrown technology but also positions India as a key player in the global push for advanced transport systems.
MORE NEWS
September 30, 2026 - 21:59
Micron Technology Tops Lofty Fiscal Q4 Goals, Guides Above ViewsMicron Technology exceeded analyst expectations for its fiscal fourth quarter, delivering results that outperformed even the most optimistic projections on Wall Street. The memory chip maker...
September 30, 2026 - 01:50
Space Force Turns to Laser Systems to Shield Launch Sites from Drone ThreatsThe U.S. Space Force is moving forward with plans to deploy laser technology as part of a broader effort to defend its launch facilities from unauthorized drones. The initiative focuses on...
September 29, 2026 - 04:58
DIU Seeks Investors in Counter-Unmanned Systems TechnologyThe Defense Innovation Unit is looking for private investors to back companies working on counter unmanned systems technology. The effort targets firms building tools to detect, track, and disable...
September 28, 2026 - 02:02
Novo Nordisk (CPSE:NOVO B) Secures Long-Acting Injectable Technology In €1.165 Billion Nanexa Licensing AgreementNovo Nordisk has entered a global licensing agreement with Swedish drug delivery company Nanexa, valued at up to 1.165 billion euros. The deal centers on Nanexa`s PharmaShell technology, a platform...